Actos And Cancer Risk

Posted by admin on December 1st, 2011

Takeda Pharmaceuticals, maker of the type II diabetes medication Actos, submitted data from an ongoing 10-year study examining the Actos and cancer risk link to the...

Actos And Bladder Cancer Lawsuit

Posted by admin on November 14th, 2011

The FDA announced in June 2011 that using the medication for longer than one year may contribute to Actos causing bladder cancer.Takeda Pharmaceuticals, maker of the...

Actos And Bladder Cancer

Posted by admin on November 1st, 2011

Actos was introduced to the U.S. market in 1999, and is prescribed to treat diabetes mellitus type 2. Recently there have been concerns regarding the link between Actos...

Actos Causing Bladder Cancer

Posted by admin on October 14th, 2011

If you have diabetes and have been using the prescription medicine Actos, you may be concerned about recent studies linking Actos causing bladder cancer.

What...

Actos Bladder Cancer FDA

Posted by admin on October 7th, 2011

On June 15, 2011, the Food and Drug Administration updated their Actos bladder cancer FDA safety information on the type 2 diabetes medication Actos (brand...

Actos Side Effects Cancer

Posted by admin on October 1st, 2011

The type II diabetes drug pioglitazone (sold under the trade name Actos) has come under intense scrutiny since 2010 regarding its link to an increased risk of Actos side effects...

Making A Difference

We believe that the manufacturer of Actos should be held accountable for any harm they are legally responsible for and patients should be fairly compensated for their damages due to a diagnosis of cancer... find out more

Contact Us For A Free Consultation

Please fill out our contact form and a lawyer will contact you for a free no-obligation case review.
  • This field is for validation purposes and should be left unchanged.

Requesting a free legal consultation does not create an attorney-client relationship and you are not considered a client until a representation agreement has been signed and your case has been accepted.

State Resources

Actos Bladder Cancer FDA

In June, 2011 the FDA approved Actos drug labeling changes that involved updated safety information regarding the higher Actos cancer risk for developing bladder cancer for patients using the drug for longer than one year. In addition, the updated warning label included information warning... find out more